Athersys Receives U.S. Patent Covering the Treatment of Cardiovascular Disease ... MarketWatch (press release) The Company currently has several clinical stage programs, including for treating damage caused by myocardial infarction, bone marrow transplantation and oncology treatment support, ischemic stroke, and inflammatory bowel disease. ... |
